78 results on '"Perez-Mancera, Pedro A."'
Search Results
2. Figure S6 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
3. Supplementary Table S12 from Tissue-Specific Oncogenic Activity of KRASA146T
4. Supplementary Tables S14-S17 from Tissue-Specific Oncogenic Activity of KRASA146T
5. Data from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
6. Figure S1 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
7. Figure S7 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
8. Data from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
9. Data from Tissue-Specific Oncogenic Activity of KRASA146T
10. Supplementary Tables S14-S17 from Tissue-Specific Oncogenic Activity of KRASA146T
11. Figure S8 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
12. Supplementary Table S13 from Tissue-Specific Oncogenic Activity of KRASA146T
13. Figure S4 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
14. Data from Tissue-Specific Oncogenic Activity of KRASA146T
15. Supplementary Tables S2-S10 from Tissue-Specific Oncogenic Activity of KRASA146T
16. Supplementary Table S11 from Tissue-Specific Oncogenic Activity of KRASA146T
17. Figure S5 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
18. Supplementary Table S1 from Tissue-Specific Oncogenic Activity of KRASA146T
19. Supplementary Table S12 from Tissue-Specific Oncogenic Activity of KRASA146T
20. Figure S2 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
21. Figure S3 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
22. Figure S2 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
23. Figure S4 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
24. Supplementary Figures S1-S18 from Tissue-Specific Oncogenic Activity of KRASA146T
25. Supplementary Tables S2-S10 from Tissue-Specific Oncogenic Activity of KRASA146T
26. Figure S6 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
27. Supplementary Table S11 from Tissue-Specific Oncogenic Activity of KRASA146T
28. Supplementary Table S1 from Tissue-Specific Oncogenic Activity of KRASA146T
29. Figure S1 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
30. Figure S5 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
31. Supplementary Figures S1-S18 from Tissue-Specific Oncogenic Activity of KRASA146T
32. Figure S8 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
33. Supplementary Table S13 from Tissue-Specific Oncogenic Activity of KRASA146T
34. Supplementary Table 3 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
35. Supplementary Table 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
36. Supplementary Table 4 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
37. Data from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
38. Supplemental Methods from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
39. Supplementary Figure Legends, Supplementary Tables 1 and 2 and Supplementary Materials and Methods from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
40. Supplementary Table 3 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
41. Supplementary Figures 1 through 9 from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
42. Data from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
43. Data from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
44. Supplementary Table 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
45. Supplementary Figure 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
46. Supplementary Figure Legends, Supplementary Tables 1 and 2 and Supplementary Materials and Methods from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
47. Supplementary Figure 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
48. Supplemental Methods from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
49. Supplementary Table 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
50. Supplementary Figure 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.